Medtronic plc

NYSE:MDT

Medical - Devices

Healthcare
$100.72 +0.96%

+$0.75 today

Market cap
$128.84B
Beta
0.60
P/E (TTM)
21.1
EPS (TTM)
$3.74
Dividend yield
3.60%
52W Low $73.31High $106.33

Volume 6.47M

Average 11.36M

MDT Operating Margin

Operating income as a percentage of revenue, showing the profitability of core operations.

Medtronic plcNYSE: MDT

Operating Margin · Q1 FY2027 · quarter ended Jul 2026

Operating margin widens to 18.1%

Operating margin was 18.1% in Q1 FY2027, up 1.2 pp from a year earlier. On a trailing-twelve-month basis it was 18.1%, up 0.2 pp year over year. Over 3 fiscal years it widened by 0.2 pp.

Context

  • Operating margin widened in 2 of the last 3 fiscal years.
  • FY2026 was the highest level in the 4 fiscal years shown.

What to watch

Whether operating margin reaches the consensus estimate from 21 analysts of 26.6% for the fiscal year ending Apr 2027, up from 17.8% in FY2026.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJul 2026
18.1%-1.0 pp QoQ
Last fiscal yearApr 2026
17.8%+0.0 pp YoY
LTMJul 2026
18.1%+0.2 pp YoY
Operating Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+1.2 pp+5.8 pp+4.6 pp
1 year+0.0 pp+8.8 pp+8.8 pp
3 years+0.2 pp+10.0 pp+9.8 pp
5 years+12.2 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Operating Margin history

Percent of revenue · from the income statement

Latest · FY2026
17.8%
Year-over-year change
+0.0pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Operating Margin vs competitors

How MDT compares with its peers on the latest reported figures

  • MDT's LTM Jul 2026 operating margin of 18.1% is the 4th highest of the 9 companies compared; the peer median is 14.1%.
  • Its year-over-year change of +0.2 pp is the 5th highest of 9, against a peer median of +0.2 pp.
  • Over three fiscal years its change of +0.2 pp compares with a peer median of +6.0 pp.
MDT Competitors Peer median
Operating Margin for MDT and competitors
Company Period LTM level YoY 3-year change
EWEdwards Lifesciences CorporationLTM Jun 202628.1% +1.9 pp-4.7 pp
SYKStryker CorporationLTM Jun 202622.0% +0.3 pp-0.8 pp
BSXBoston Scientific CorporationLTM Jun 202621.5% +5.4 pp+5.4 pp
MDTMedtronic plcLTM Jul 202618.1% +0.2 pp+0.2 pp
ZBHZimmer Biomet Holdings, Inc.LTM Jun 202615.7% -0.4 pp+6.5 pp
PENPenumbra, Inc.LTM Jun 202612.4% +0.0 pp+12.8 pp
LIVNLivaNova PLCLTM Sep 202611.5% -2.9 pp+21.9 pp
PHGKoninklijke Philips N.V.LTM Jun 20269.7% +3.6 pp+16.6 pp
AVRAnteris Technologies Global Corp.LTM Mar 2026-5192.9% -1839.0 pp-3936.1 pp
Peer median (excluding MDT) 14.1%+0.2 pp+6.0 pp

Competitors are the stored peer set for MDT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Apr 2022
FY2023
Apr 2023
FY2024
Apr 2024
FY2025
Apr 2025
FY2026
Apr 2026
Revenue31.69B31.23B32.36B33.54B36.36B
Cost of Revenue10.15B10.72B11.22B11.63B12.72B
Gross Profit21.54B20.51B21.15B21.91B23.64B
Gross Margin68.0%65.7%65.3%65.3%65.0%
Research & Development2.75B2.7B2.74B2.73B2.87B
Selling, General & Admin10.29B10.42B10.74B10.85B11.78B
Operating Expenses15.79B15.02B16B15.95B17.18B
Depreciation & Amortization2.71B2.7B2.65B2.86B2.96B
EBITDA8.78B8.7B8.2B9.22B9.81B
EBITDA Margin27.7%27.9%25.3%27.5%27.0%
Operating Income5.75B5.49B5.14B5.96B6.47B
Operating Margin18.2%17.6%15.9%17.8%17.8%
Interest Income00000
Interest Expense553M636M719M729M715M
Other Income / Expenses(235M)(121M)(307M)(327M)(331M)
Income Before Tax5.52B5.36B4.84B5.63B6.14B
Pre-Tax Margin17.4%17.2%14.9%16.8%16.9%
Income Tax Expense456M1.58B1.13B936M1.3B
Net Income5.04B3.76B3.68B4.66B4.8B
Net Margin15.9%12.0%11.4%13.9%13.2%
EPS (Basic)3.752.832.773.633.75
EPS (Diluted)3.732.822.763.613.73
Weighted Avg Shares1.34B1.33B1.33B1.29B1.28B
Weighted Avg Shares (Diluted)1.35B1.33B1.33B1.29B1.29B

Medtronic plc

NYSE:MDT

Intrinsic Alpha fair value

Locked

Current Price

$100.72

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.